The application of exposure therapy and D-cycloserine to the treatment of anorexia nervosa: A preliminary trial

Journal of Psychiatric Practice

Volumn 13, Issue 4, 2007, Pages 238-245

  Steinglass, Joanna ^a,b   Sysko, Robyn ^b   Schebendach, Janet ^a   Broft, Allegra ^a   Strober, Michael ^c   Walsh, B Timothy ^a  

^a New York State Psychiatric Institute ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anorexia nervosa; D cycloserine; Eating disorders; Exposure therapy; Phobia

Indexed keywords

CYCLOSERINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADULT; ANOREXIA NERVOSA; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EATING DISORDER; EXPOSURE THERAPY INTERVENTION; FEMALE; HUMAN; INTERVENTION STUDY; PHOBIA; RANDOMIZED CONTROLLED TRIAL; TEST MEAL; TREATMENT OUTCOME;

ADULT; ANOREXIA NERVOSA; ANXIETY DISORDERS; BODY MASS INDEX; COMBINED MODALITY THERAPY; CYCLOSERINE; DESENSITIZATION, PSYCHOLOGIC; DOUBLE-BLIND METHOD; EATING; ENERGY INTAKE; EXCITATORY AMINO ACID AGONISTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; PAIN MEASUREMENT; PATIENT ADMISSION; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 34547657608     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000281484.89075.a8     Document Type: Article

References (29)

1. Sullivan PF. Mortality in anorexia nervosa. Am J Psychiatry 1995;152:1073-5.
2. Zhu AJ, Walsh BT. Pharmacologic treatment of eating disorders. Can J Psychiatry 2002;47:227-4.
3. Attia E, Mayer L, Killory E. Medication response in the treatment of patients with anorexia nervosa. J Psychiatr Pract 2001;7:157-62.
4. Walsh BT, Kaplan AS, Attia E, et al. Fluoxetine after weight restoration in anorexia nervosa: A randomized controlled trial. JAMA 2006;295:2605-12.
5. le Grange D, Lock J. The dearth of psychological treatment studies for anorexia nervosa. Int J Eat Disord 2005;37:79-91.
6. Strober M. Pathologic fear conditioning and anorexia nervosa: On the search for novel paradigms. Int J Eat Disord 2004;35:504-8.
7. Bulik CM, Sullivan PF, Fear JL, et al. Eating disorders and antecedent anxiety disorders: A controlled study. Acta Psychiatr Scand 1997;96:101-7.
8. Silberg JL, Bulik CM. The developmental association between eating disorders symptoms and symptoms of depression and anxiety in juvenile twin girls. J Child Psychol Psychiatry 2005;46:1317-26.
9. Barlow DH, Durand VM. Abnormal psychology: An integrative approach, 4th ed. Belmont, CA: Thompson-Wadsworth; 2005.
10. Halmi KA, Sunday SR. Temporal patterns of hunger and fullness ratings and related cognitions in anorexia and bulimia. Appetite 1991;16:219-37.
11. Sysko R, Walsh BT, Schebendach J, et al. Eating behavior among women with anorexia nervosa. Am J Clin Nutr 2005;82:296-301.
12. Walker DL, Ressler KJ, Lu K-T, et al. Facilitation of conditioned fear extinction by systemic administration or intraamygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 2002;22:2343-51.
13. Ledgerwood L, Richardson R, Cranney J. Effects of D-cycloserine on extinction of conditioned freezing. Behav Neurosci 2003;117:341-9.
14. Ressler KJ, Rothbaum BO, Tannenbaum L, et al. Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 2004;61:1136-44.
15. Hofmann SG, Meuret AE, Smits JA, et al. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry 2006;63:298-304.
16. Bulik CM, Sullivan PF, Carter FA, et al. The role of exposure with response prevention in the cognitive-behavioural therapy for bulimia nervosa. Psychol Med 1998;28:611-23.
17. Carter FA, McIntosh VV, Joyce PR, et al. Role of exposure with response prevention in cognitive-behavioral therapy for bulimia nervosa: Three-year follow-up results. Int J Eat Disord 2003;33:127-35.
18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition, text revision. Washington, DC: American Psychiatric Association; 2000.
19. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCIDP), version 2. New York: New York State Psychiatric Institute, Biometrics Research; 1995.
20. Watson TL, Andersen AE. A critical examination of the amenorrhea and weight criteria for diagnosing anorexia nervosa. Acta Psychiatr Scand 2003;108:175-82.
21. MetropolitanLifeInsurance. New weight standards for men and women. Statistical Bulletin 1959 (40):1-4.
22. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
23. Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 1988;56:893-7.
24. Cohen J, Cohen P. Applied multiple regression/correlation analysis for the behavioral sciences, 2nd edition. Hillsdale, NJ: Erlbaum; 1983.
25. Bergh C, Brodin U, Lindberg G, et al. Randomized controlled trial of a treatment for anorexia and bulimia nervosa. Proc Natl Acad Sci USA 2002;99:9486-91.
26. Key A, George CL, Beattie D, et al. Body image treatment within an inpatient program for anorexia nervosa: The role of mirror exposure in the desensitization process. Int J Eat Disord 2002;31:185-90.
27. Boutelle KN. The use of exposure with response prevention in a male anorexic. J Behav Ther Exp Psychiatry 1998;29:79-84.
28. Pliner P, Mann N. Influence of social norms and palatability on amount consumed and food choice. Appetite 2004;42: 227-37.
29. Pliner P, Pelchat M, Grabski M. Reduction of neophobia in humans by exposure to novel foods. Appetite 1993;20:111-23.